These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

876 related items for PubMed ID: 23205939

  • 1. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
    Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS.
    Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
    Vannucchi G, Covelli D, Campi I, Currò N, Dazzi D, Rodari M, Pepe G, Chiti A, Guastella C, Lazzaroni E, Salvi M.
    Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
    Kaplowitz PB, Jiang J, Vaidyanathan P.
    J Pediatr Endocrinol Metab; 2020 Mar 26; 33(3):383-389. PubMed ID: 31603857
    [Abstract] [Full Text] [Related]

  • 6. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA, Zang S, Kahaly GJ.
    Thyroid; 2010 Jul 26; 20(7):785-93. PubMed ID: 20578895
    [Abstract] [Full Text] [Related]

  • 7. Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study.
    Król A, Koehler A, Nowak M, Paliczka-Cieślik E, Krajewska J, Kalemba M, Jurecka-Lubieniecka B, Hasse-Lazar K, Michalik B, Szpak-Ulczok S, Zarudzki Ł, Roskosz J, Jarząb B.
    Endokrynol Pol; 2014 Jul 26; 65(1):40-5. PubMed ID: 24549601
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radioactive iodine treatment for Graves' hyperthyroidism: incidence of Graves orbitopathy.
    Quah NQX, Sobti MM, Wren AM, Scawn R, Kalogianni E, Cleland J, Maenhout A.
    Nucl Med Commun; 2024 Feb 01; 45(2):103-107. PubMed ID: 37982569
    [Abstract] [Full Text] [Related]

  • 10. Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests.
    Sheehan MT, Doi SA.
    Clin Med Res; 2016 Mar 01; 14(1):40-5. PubMed ID: 26864507
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up.
    Czarnywojtek A, Komar-Rychlicka K, Zgorzalewicz-Stachowiak M, Sawicka-Gutaj N, Woliński K, Gut P, Płazinska M, Torlińska B, Florek E, Waligórska-Stachura J, Ruchała M.
    Pol Arch Med Wewn; 2016 Aug 18; 126(10):746-753. PubMed ID: 27534827
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L, Lundell G, Tørring O, Wallin G, Ljunggren JG, Blomgren H, Taube A.
    N Engl J Med; 1992 Jun 25; 326(26):1733-8. PubMed ID: 1489388
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jan 25; 95(1):201-8. PubMed ID: 19906789
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.